AC
AnkiCollab
AnkiCollab
Sign in
Explore Decks
Helpful
Join Discord
Download Add-on
Documentation
Support Us
Notes in
DLBCL
To Subscribe, use this Key
cat-friend-lactose-spaghetti-georgia-hot
Status
Last Update
Fields
Published
02/18/2024
Haem | Aggressive NHL | 0 | List the entities considered to be "aggressive non-hodgkin lymphomas"
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.1.1 | Epidemiology | Describe the epidemiology of diffuse large B cell lymphoma
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.2 | Clinical features | Describe the clinical features of DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.3.1 | Patholology | Briefly describe the macroscopic features, microscopic features, immunophenotype and c…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.4 | Natural history | Describe the natural history of DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.1.1 | Management Overview | Provide a brief overview of initial management for patients with DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.2.1 | Management | Principles of chemotherapy | List the agents in R-CHOP
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.2.2 | Management | Principles of chemotherapy | How is R-CHOP given
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.2.4 | Management | Principles of chemotherapy | List the major side effects associated with each agent in …
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.2.3 | Management | Principles of chemotherapy | Rituximab | Briefly discuss the mechanism of action, effic…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.0 | Stage I-II | RT | Discuss the evidence for radiotherapy in stage I-II DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.4.2 | Stage III-IV | RT | Discuss the role of radiotherapy in stage III-IV DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.6 | Role of RT in rituximab era | Briefly discuss the role of radiotherapy in DLBCL in the rituximab era
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 3.1 | RT planning | Describe a suitable radiotherapy technique (ISRT) for RT as a component of the initial m…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 5.1.1 | Relapsed and refractory disease | Discuss the management of relapsed and refractory DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 4.2 | Long term treatment complications | Briefly discuss the major long term complications of treatment for…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 4.3 | Follow up | Provide a suitable follow up schedule following completion of therapy for DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.1.2 | Aetiology and pathogenesis | Briefly discuss the pathogenesis of DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.1.3 | Clinicopathologic subtypes | Briefly list the distinctive clinicopathologic subtypes of DLBCL …
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.3.2 | Patholology | Create a table to differentiate between DLBCL, Burkitt lymphoma, anaplastic large cell…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.6 | Workup | Describe your workup for suspected lymphoma / DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.3.3 | Differential diagnosis | Provide a DDx for DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.2 | Stage I-II | Special senarios | Testicular DLBCL | Discuss management of testicular DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.1 || Stage I-II Special senarios | Bulk | Discuss treatment for stage I-II bulky DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.3 | Stage I-II | Special senarios | Gastrointestinal DLBCL | Discuss the management of gastro…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.4 | Stage I-II | Special senarios | CNS involvement | Discuss the managemnent of DLBCL involving th…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.5 | Stage I-II | Special senarios | Ovarian involvement | Discuss the management of primary ovarian…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.3.6 | Stage I-II | Special senarios | Breast | Discuss management of primary DLBCL of the breast
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.7 | Staging | Describe the staging of DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.8 | Prognosis | What is the prognosis for stage I-II and stage III-IV DLBCL, IPI score
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.4.1 | Stage III-IV | Chemotherapy regimen | Discuss the optimal chemotherapy regimen for stage III-IV DLBC…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.5.1 | Stage III-IV | Special scenarios | Older patients | Discuss management of older patients with NHL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.5.2 | Stage III-IV | Special scenarios | Cardiac disease | Discuss management of patients with cardiac dis…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 5.1.1 | Relapsed and refractory disease | Overview | Provide a brief overview of the management of relapsed …
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 5.1.2 | Relapsed and refractory DLBCL | Role of RT | Discuss the role of radiotherapy in relapsed and refrac…
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.1.3 | Management | Principles of RT | RT dose | Discuss appropriate dose/fractionation for aggressive NHL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 2.1.2 | Management Overview | Overview of role of RT | Provide a brief overview of the role of RT in DLBCL
Published
02/18/2024
Haem | Aggressive NHL | 1 | DLBCL | 1.1.2.1 | Risk factors
Status
Last Update
Fields